Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: Results of a multicenter study

Journal of Autoimmunity

Volumn 51, Issue , 2014, Pages 75-80

  Quartuccio, Luca ^a   Isola, Miriam ^b   Baldini, Chiara ^c   Priori, Roberta ^d   Bartoloni Bocci, Elena ^e   Carubbi, Francesco ^f   Maset, Marta ^a   Gregoraci, Giorgia ^b   Della Mea, Vincenzo ^b   Salvin, Sara ^a   De Marchi, Ginevra ^a   Luciano, Nicoletta ^c   Colafrancesco, Serena ^d   Alunno, Alessia ^e   Giacomelli, Roberto ^f   Gerli, Roberto ^e   Valesini, Guido ^d   Bombardieri, Stefano ^c   De Vita, Salvatore ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Cryoglobulinemia; Lymphoma; Sj gren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C4 ANTIBODY; CRYOGLOBULIN; LA ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; B CELL LYMPHOMA; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CRYOGLOBULINEMIA; CRYOGLOBULINEMIC VASCULITIS; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HYPERGAMMAGLOBULINEMIA; LEUKOPENIA; LYMPHOCYTE PROLIFERATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SALIVARY GLAND DISEASE; SALIVARY GLAND SWELLING; SJOEGREN SYNDROME; VASCULITIS; CLINICAL TRIAL; COMPLICATION; IMMUNOLOGY; METABOLISM; MULTICENTER STUDY; PATHOLOGY; PRECANCER; RISK;

ADULT; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; RISK; SJOGREN'S SYNDROME;

EID: 84901267943     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.10.002     Document Type: Article

References (37)

1. Tzioufas A.G., Katsikis P.D., Youinou P.Y., Moutsopoulos H.M. Sjögren's syndrome: an oligo-monoclonal B cells process. Clin Exp Rheumatol 1990, 8(Suppl.5):17-21.
2. Tzioufas A.G., Youinou P., Moutsopoulos H.M. Sjögren's syndrome. Oxford textbook of rheumatology 2004, 921-933. Oxford University Press. 3rd ed. D.A. Isenberg, P. Maddison, P. Woo, D. Glass, F. Breedveld (Eds.).
3. Voulgarelis M., Dafni U.G., Isenberg D.A., Moutsopoulos H.M. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999, 42(8):1765-1772.
4. Baimpa E., Dahabreh I.J., Voulgarelis M., Moutsopoulos H.M. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009, 88(5):284-293.
5. Sutcliffe N., Inanc M., Speight P., Isenberg D. Predictors of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum 1998, 28(2):80-87.
6. Theander E., Henriksson G., Ljungberg O., Mandl T., Manthorpe R., Jacobsson L.T. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006, 65(6):796-803.
7. Brito-Zerón P., Ramos-Casals M., Bove A., Sentis J., Font J. Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors. Rheumatology (Oxford) 2007, 46(8):1359-1362.
8. Tzioufas A.G., Boumba D.S., Skopouli F.N., Moutsopoulos H.M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1996, 39(5):767-772.
9. Anaya J.M., McGuff H.S., Banks P.M., Talal N. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome. Semin Arthritis Rheum 1996, 25(5):337-346.
10. De Vita S., Boiocchi M., Sorrentino D., Carbone A., Avellini C., Dolcetti R., et al. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum 1997, 40(2):318-331.
11. De Vita S., De Marchi G., Sacco S., Gremese E., Fabris M., Ferraccioli G. Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells Mol Dis 2001, 27(4):757-766.
12. Voulgarelis M., Tzioufas A.G., Moutsopoulos H.M. Mortality in Sjögren's syndrome. Clin Exp Rheumatol 2008 Sep-Oct, 26(5 Suppl.51):S66-S71.
13. Gasparotto D., De Vita S., De Re V., Marzotto A., De Marchi G., Scott C.A., et al. Extrasalivary lymphoma development in Sjögren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering. Arthritis Rheum 2003, 48(11):3181-3186.
14. Ramos-Casals M., Solans R., Rosas J., Camps M.T., Gil A., Del Pino-Montes J., et al. Primary Sjogren's syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008, 87:210-219.
15. De Vita S., Quartuccio L., Salvin S., Corazza L., Zabotti A., Fabris M. Cryoglobulinaemia related to Sjögren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. Rheumatology (Oxford) 2012, 51(4):627-633.
16. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
17. Baldini C., Pepe P., Quartuccio L., Priori R., Bartoloni Bocci E., Alunno A., et al. Correlation of clinical, serological and histologic findings in a large cohort of primary Sjögren's syndrome patients: a multicentric cross-sectional study. Ann Rheum Dis 2012, 71(Suppl.3):542.
18. Vitali C., Bombardieri S., Moutsopoulos H.M., Coll J., Gerli R., Hatron P.Y., et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993, 36:340-347.
19. Brouet J.C., Clauvel J.P., Danon F., Klein M., Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974, 57:775-788.
20. De Vita S., Soldano F., Isola M., Monti G., Gabrielli A., Tzioufas A., et al. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis 2011, 70(7):1183-1190.
21. Quartuccio L., Isola M., Corazza L., Maset M., Monti G., Gabrielli A., et al. Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol 2012, 30(1 Suppl 70):S48-S52.
22. Martin T., Weber J.C., Levallois H., Labouret N., Soley A., Koenig S., et al. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum 2000, 43(4):908-916.
23. De Re V., De Vita S., Gasparotto D., Marzotto A., Carbone A., Ferraccioli G., et al. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkin's lymphoma. Eur J Immunol 2002, 32(3):903-910.
24. Skopouli F.N., Dafni U., Ioannidis J.P., Moutsopoulos H.M. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000, 29(5):296-304.
25. Solans-Laque R., Lopez-Hernandez A., Bosch-Gil J.A., Palacios A., Campillo M., Vilardell-Tarres M. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum 2011, 41(3):415-423.
26. Baldini C., Pepe P., Luciano N., Ferro F., Talarico R., Grossi S., et al. Aclinical prediction rule for lymphoma development in primary Sjögren's syndrome. JRheumatol 2012, 39(4):804-808.
27. Anderson L.G., Cummings N.A., Asofsky R., Hylton M.B., Tarpley T.M., Tomasi T.B., et al. Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment. Am J Med 1972, 53(4):456-463.
28. Sugai S., Shimizu S., Tachibana J., Imaoka S., Konda S. Ahigh incidence of rheumatoid factor idiotypes in monoclonal proteins in the serum and in lymphoma cells in patients with Sjögren's syndrome. JAutoimmun 1989, 2(4):471-476.
29. Kipps T.J., Tomhave E., Chen P.P., Fox R.I. Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjogren's syndrome. JImmunol 1989, 142(12):4261-4268.
30. Shokri F., Mageed R.A., Maziak B.R., Talal N., Amos N., Williams B.D., et al. Lymphoproliferation in primary Sjögren's syndrome. Evidence of selective expansion of a B cell subset characterized by the expression of cross-reactive idiotypes. Arthritis Rheum 1993, 36(8):1128-1136.
31. Mariette X., Roux S., Zhang J., Bengoufa D., Lavie F., Zhou T., et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis 2003, 62:168-171.
32. Daridon C., Devauchelle V., Hutin P., Le Berre R., Martins-Carvalho C., Bendaoud B., et al. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2007, 56(4):1134-1144.
33. Quartuccio L., Salvin S., Fabris M., Maset M., Pontarini E., Isola M., et al. BLyS upregulation in Sjögren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands. Rheumatology (Oxford) 2013, 52(2):276-281.
34. Huang M., Ida H., Kamachi M., Iwanaga N., Izumi Y., Tanaka F., et al. Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjögren's syndrome. Clin Exp Immunol 2005, 142:148-154.
35. Fabris M., Quartuccio L., Sacco S., De Marchi G., Pozzato G., Mazzaro C., et al. B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection. Rheumatology (Oxford) 2007 Jan, 46(1):37-43.
36. Monti G., Pioltelli P., Saccardo F., Campanini M., Candela M., Cavallero G., et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 2005, 165(1):101-105.
37. Morra E., Cesana C., Klersy C., Barbarano L., Varettoni M., Cavanna L., et al. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders. Leukemia 2004, 18(9):1512-1517.